Circumvent
Utilizing monogenic disorders to inform and solve highly complex…
United States · $495K raised
- Employees
- 1–10
- Total Funding
- $495K
- Last Round
- $495K SeedOct 2021
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Utilizing monogenic disorders to inform and solve highly complex…
Summary
Circumvent is a Biotech company based in United States. It has raised $495K in total across 2 rounds, most recently a $495K Seed round in Oct 2021. Investors include HHS NIH SBIR Phase II, Y Combinator and Heritage Provider Network.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Oct 2021
Sign up to see all 2 events
Funding: Grant through Seed. Amounts, valuations, and investors where available.
Investors
Similar Companies
Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...
Neuralink develops investigational implantable brain-computer interfaces that help people with pa...
Ultima Genomics develops high-throughput DNA sequencing platforms that use open-wafer technology ...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/circumvent-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/circumvent-pharmaceuticals" alt="Circumvent on Indexed.vc" width="260" height="76" /></a>